Log in
NASDAQ:CLXT

Calyxt Competitors

$3.71
-0.10 (-2.62 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.65
Now: $3.71
$3.86
50-Day Range
$3.69
MA: $5.38
$6.38
52-Week Range
$2.40
Now: $3.71
$8.41
Volume103,816 shs
Average Volume113,161 shs
Market Capitalization$123.11 million
P/E RatioN/A
Dividend YieldN/A
Beta2.29

Competitors

Calyxt (NASDAQ:CLXT) Vs. NTR, SMG, MOS, CF, ICL, and AVD

Should you be buying CLXT stock or one of its competitors? Companies in the industry of "agricultural chemicals" are considered alternatives and competitors to Calyxt, including Nutrien (NTR), The Scotts Miracle-Gro (SMG), The Mosaic (MOS), CF Industries (CF), ICL Group (ICL), and American Vanguard (AVD).

Calyxt (NASDAQ:CLXT) and Nutrien (NYSE:NTR) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.

Risk and Volatility

Calyxt has a beta of 2.29, suggesting that its stock price is 129% more volatile than the S&P 500. Comparatively, Nutrien has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500.

Earnings & Valuation

This table compares Calyxt and Nutrien's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calyxt$7.30 million16.86$-39,610,000.00($1.21)-3.07
Nutrien$20.02 billion1.18$992 million$2.1719.16

Nutrien has higher revenue and earnings than Calyxt. Calyxt is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings for Calyxt and Nutrien, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Calyxt05102.17
Nutrien071312.71

Calyxt currently has a consensus price target of $7.20, suggesting a potential upside of 94.07%. Nutrien has a consensus price target of $46.2941, suggesting a potential upside of 11.36%. Given Calyxt's higher probable upside, equities research analysts clearly believe Calyxt is more favorable than Nutrien.

Profitability

This table compares Calyxt and Nutrien's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Calyxt-392.49%-77.67%-54.49%
Nutrien4.08%4.26%2.03%

Insider and Institutional Ownership

24.1% of Calyxt shares are held by institutional investors. Comparatively, 63.2% of Nutrien shares are held by institutional investors. 2.3% of Calyxt shares are held by insiders. Comparatively, 3.1% of Nutrien shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Nutrien beats Calyxt on 12 of the 15 factors compared between the two stocks.

Calyxt (NASDAQ:CLXT) and The Scotts Miracle-Gro (NYSE:SMG) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.

Insider and Institutional Ownership

24.1% of Calyxt shares are held by institutional investors. Comparatively, 64.9% of The Scotts Miracle-Gro shares are held by institutional investors. 2.3% of Calyxt shares are held by insiders. Comparatively, 28.2% of The Scotts Miracle-Gro shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

Calyxt has a beta of 2.29, suggesting that its stock price is 129% more volatile than the S&P 500. Comparatively, The Scotts Miracle-Gro has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for Calyxt and The Scotts Miracle-Gro, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Calyxt05102.17
The Scotts Miracle-Gro03302.50

Calyxt currently has a consensus price target of $7.20, suggesting a potential upside of 94.07%. The Scotts Miracle-Gro has a consensus price target of $130.80, suggesting a potential downside of 17.70%. Given Calyxt's higher probable upside, equities research analysts clearly believe Calyxt is more favorable than The Scotts Miracle-Gro.

Profitability

This table compares Calyxt and The Scotts Miracle-Gro's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Calyxt-392.49%-77.67%-54.49%
The Scotts Miracle-Gro8.71%45.36%9.86%

Earnings & Valuation

This table compares Calyxt and The Scotts Miracle-Gro's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calyxt$7.30 million16.86$-39,610,000.00($1.21)-3.07
The Scotts Miracle-Gro$3.16 billion2.81$460.70 million$4.4735.55

The Scotts Miracle-Gro has higher revenue and earnings than Calyxt. Calyxt is trading at a lower price-to-earnings ratio than The Scotts Miracle-Gro, indicating that it is currently the more affordable of the two stocks.

Summary

The Scotts Miracle-Gro beats Calyxt on 11 of the 14 factors compared between the two stocks.

The Mosaic (NYSE:MOS) and Calyxt (NASDAQ:CLXT) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.

Insider and Institutional Ownership

71.6% of The Mosaic shares are held by institutional investors. Comparatively, 24.1% of Calyxt shares are held by institutional investors. 0.5% of The Mosaic shares are held by insiders. Comparatively, 2.3% of Calyxt shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Volatility & Risk

The Mosaic has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. Comparatively, Calyxt has a beta of 2.29, indicating that its stock price is 129% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for The Mosaic and Calyxt, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Mosaic0111002.48
Calyxt05102.17

The Mosaic presently has a consensus target price of $17.3947, suggesting a potential downside of 6.98%. Calyxt has a consensus target price of $7.20, suggesting a potential upside of 94.07%. Given Calyxt's higher probable upside, analysts plainly believe Calyxt is more favorable than The Mosaic.

Profitability

This table compares The Mosaic and Calyxt's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Mosaic-12.92%-0.64%-0.31%
Calyxt-392.49%-77.67%-54.49%

Earnings and Valuation

This table compares The Mosaic and Calyxt's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Mosaic$8.91 billion0.80$-1,067,400,000.00$0.1998.42
Calyxt$7.30 million16.86$-39,610,000.00($1.21)-3.07

Calyxt has lower revenue, but higher earnings than The Mosaic. Calyxt is trading at a lower price-to-earnings ratio than The Mosaic, indicating that it is currently the more affordable of the two stocks.

Summary

The Mosaic beats Calyxt on 8 of the 14 factors compared between the two stocks.

CF Industries (NYSE:CF) and Calyxt (NASDAQ:CLXT) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.

Earnings and Valuation

This table compares CF Industries and Calyxt's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CF Industries$4.59 billion1.29$493 million$1.9314.29
Calyxt$7.30 million16.86$-39,610,000.00($1.21)-3.07

CF Industries has higher revenue and earnings than Calyxt. Calyxt is trading at a lower price-to-earnings ratio than CF Industries, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

CF Industries has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Calyxt has a beta of 2.29, indicating that its stock price is 129% more volatile than the S&P 500.

Insider and Institutional Ownership

92.1% of CF Industries shares are held by institutional investors. Comparatively, 24.1% of Calyxt shares are held by institutional investors. 2.0% of CF Industries shares are held by insiders. Comparatively, 2.3% of Calyxt shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares CF Industries and Calyxt's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CF Industries8.87%6.76%3.05%
Calyxt-392.49%-77.67%-54.49%

Analyst Ratings

This is a summary of recent recommendations and price targets for CF Industries and Calyxt, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CF Industries19802.39
Calyxt05102.17

CF Industries presently has a consensus target price of $40.80, suggesting a potential upside of 47.93%. Calyxt has a consensus target price of $7.20, suggesting a potential upside of 94.07%. Given Calyxt's higher probable upside, analysts plainly believe Calyxt is more favorable than CF Industries.

Summary

CF Industries beats Calyxt on 10 of the 14 factors compared between the two stocks.

ICL Group (NYSE:ICL) and Calyxt (NASDAQ:CLXT) are both basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Earnings & Valuation

This table compares ICL Group and Calyxt's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICL Group$5.27 billion0.91$475 million$0.3710.08
Calyxt$7.30 million16.86$-39,610,000.00($1.21)-3.07

ICL Group has higher revenue and earnings than Calyxt. Calyxt is trading at a lower price-to-earnings ratio than ICL Group, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

ICL Group has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Calyxt has a beta of 2.29, meaning that its share price is 129% more volatile than the S&P 500.

Insider & Institutional Ownership

4.3% of ICL Group shares are owned by institutional investors. Comparatively, 24.1% of Calyxt shares are owned by institutional investors. 2.3% of Calyxt shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares ICL Group and Calyxt's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ICL Group1.41%7.76%3.35%
Calyxt-392.49%-77.67%-54.49%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for ICL Group and Calyxt, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ICL Group01002.00
Calyxt05102.17

Calyxt has a consensus target price of $7.20, suggesting a potential upside of 94.07%. Given Calyxt's stronger consensus rating and higher probable upside, analysts clearly believe Calyxt is more favorable than ICL Group.

American Vanguard (NYSE:AVD) and Calyxt (NASDAQ:CLXT) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Earnings & Valuation

This table compares American Vanguard and Calyxt's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Vanguard$468.19 million0.92$13.60 million$0.4631.09
Calyxt$7.30 million16.86$-39,610,000.00($1.21)-3.07

American Vanguard has higher revenue and earnings than Calyxt. Calyxt is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

American Vanguard has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Calyxt has a beta of 2.29, meaning that its share price is 129% more volatile than the S&P 500.

Insider & Institutional Ownership

77.4% of American Vanguard shares are owned by institutional investors. Comparatively, 24.1% of Calyxt shares are owned by institutional investors. 5.3% of American Vanguard shares are owned by company insiders. Comparatively, 2.3% of Calyxt shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares American Vanguard and Calyxt's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
American Vanguard2.41%3.24%1.64%
Calyxt-392.49%-77.67%-54.49%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for American Vanguard and Calyxt, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
American Vanguard0000N/A
Calyxt05102.17

Calyxt has a consensus target price of $7.20, suggesting a potential upside of 94.07%. Given Calyxt's higher probable upside, analysts clearly believe Calyxt is more favorable than American Vanguard.

Summary

American Vanguard beats Calyxt on 9 of the 13 factors compared between the two stocks.


Calyxt Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Nutrien logo
NTR
Nutrien
2.1$41.57-0.7%$23.66 billion$20.02 billion28.87
The Scotts Miracle-Gro logo
SMG
The Scotts Miracle-Gro
1.8$158.93-1.3%$8.86 billion$3.16 billion27.88Heavy News Reporting
The Mosaic logo
MOS
The Mosaic
1.7$18.70-0.1%$7.09 billion$8.91 billion-6.32Analyst Downgrade
Decrease in Short Interest
CF Industries logo
CF
CF Industries
2.4$27.58-1.2%$5.90 billion$4.59 billion15.85Dividend Announcement
ICL Group logo
ICL
ICL Group
1.3$3.73-0.3%$4.77 billion$5.27 billion62.17Analyst Downgrade
American Vanguard logo
AVD
American Vanguard
1.0$14.30-1.5%$431.57 million$468.19 million37.63
Marrone Bio Innovations logo
MBII
Marrone Bio Innovations
1.3$1.23-3.3%$187.54 million$29.37 million-4.24
CVR Partners logo
UAN
CVR Partners
1.3$0.76-1.3%$84.44 million$404.18 million-0.78
Evogene logo
EVGN
Evogene
0.5$3.18-0.6%$81.89 million$750,000.00-3.98
CGA
China Green Agriculture
0.8$2.91-4.5%$18.48 million$294.32 million0.00High Trading Volume
Heavy News Reporting
SenesTech logo
SNES
SenesTech
0.8$1.75-8.6%$5.95 million$140,000.00-0.23High Trading Volume
Heavy News Reporting
This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.